Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cue Biopharma, Inc. (CUE) had Free Cash Flow per Share of $-0.11 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.42M |
|
$-12.26M |
|
-- |
|
$0.42M |
|
$12.72M |
|
$-12.30M |
|
$0.04M |
|
$-12.26M |
|
$-12.26M |
|
$-12.26M |
|
$-12.26M |
|
$-12.26M |
|
$-12.26M |
|
$-12.30M |
|
$-12.19M |
|
74.25M |
|
74.25M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$15.93M |
|
$0.52M |
|
$6.32M |
|
$22.25M |
|
$15.50M |
|
-- |
|
$0.18M |
|
$15.67M |
|
$6.58M |
|
$6.58M |
|
$6.58M |
|
61.82M |
|
| Cash Flow Statement Financials | |
$-8.17M |
|
$-0.15M |
|
$-1.00M |
|
$22.61M |
|
$13.29M |
|
$-9.32M |
|
$1.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
100.00% |
|
-2921.38% |
|
-2921.38% |
|
-- |
|
-2911.40% |
|
-2911.40% |
|
$-8.32M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-186.28% |
|
-186.28% |
|
-55.08% |
|
-186.28% |
|
$0.11 |
|
|
Free Cash Flow per Share |
$-0.11 |
$-0.11 |
|